Amelogenin as marker for bone marrow engraftment: A short-term study

Thea Pugatsch; Reuven Or; Shimon Slavin; Josef Kapelushnik

Amelogenin as marker for bone marrow engraftment: A short-term study

Thea Pugatsch, Reuven Or, Shimon Slavin, Josef Kapelushnik

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The degree of chimerism on the molecular level was determined by single-step amelogenin-PCR over the first two weeks post bone marrow transplantation for the recipient of a sex-mismatched, HLA-fully matched donor marrow. The kinetic profile of engraftment, as shown here, paralleled the development of hematopoiesis allowing detection of donor cells in the peripheral blood four days before neutrophils were visible in smears. Determination of engraftment kinetics early post transplant allows appropriate treatment of the patient and might therefore be crucial to the success of the procedure.

Original language	English
Pages (from-to)	47-51
Number of pages	5
Journal	Journal of Tumor Marker Oncology
Volume	12
Issue number	4
State	Published - 1 Dec 1997
Externally published	Yes

ASJC Scopus subject areas

Cancer Research

Cite this

@article{0e61222d1f2540a6a960373d71dd59ab,

title = "Amelogenin as marker for bone marrow engraftment: A short-term study",

abstract = "The degree of chimerism on the molecular level was determined by single-step amelogenin-PCR over the first two weeks post bone marrow transplantation for the recipient of a sex-mismatched, HLA-fully matched donor marrow. The kinetic profile of engraftment, as shown here, paralleled the development of hematopoiesis allowing detection of donor cells in the peripheral blood four days before neutrophils were visible in smears. Determination of engraftment kinetics early post transplant allows appropriate treatment of the patient and might therefore be crucial to the success of the procedure.",

author = "Thea Pugatsch and Reuven Or and Shimon Slavin and Josef Kapelushnik",

year = "1997",

month = dec,

day = "1",

language = "English",

volume = "12",

pages = "47--51",

journal = "Journal of Tumor Marker Oncology",

issn = "0886-3849",

publisher = "International Academy of Tumor Marker Oncology",

number = "4",

}

TY - JOUR

T1 - Amelogenin as marker for bone marrow engraftment

T2 - A short-term study

AU - Pugatsch, Thea

AU - Or, Reuven

AU - Slavin, Shimon

AU - Kapelushnik, Josef

PY - 1997/12/1

Y1 - 1997/12/1

N2 - The degree of chimerism on the molecular level was determined by single-step amelogenin-PCR over the first two weeks post bone marrow transplantation for the recipient of a sex-mismatched, HLA-fully matched donor marrow. The kinetic profile of engraftment, as shown here, paralleled the development of hematopoiesis allowing detection of donor cells in the peripheral blood four days before neutrophils were visible in smears. Determination of engraftment kinetics early post transplant allows appropriate treatment of the patient and might therefore be crucial to the success of the procedure.

AB - The degree of chimerism on the molecular level was determined by single-step amelogenin-PCR over the first two weeks post bone marrow transplantation for the recipient of a sex-mismatched, HLA-fully matched donor marrow. The kinetic profile of engraftment, as shown here, paralleled the development of hematopoiesis allowing detection of donor cells in the peripheral blood four days before neutrophils were visible in smears. Determination of engraftment kinetics early post transplant allows appropriate treatment of the patient and might therefore be crucial to the success of the procedure.

UR - http://www.scopus.com/inward/record.url?scp=33750035187&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33750035187

SN - 0886-3849

VL - 12

SP - 47

EP - 51

JO - Journal of Tumor Marker Oncology

JF - Journal of Tumor Marker Oncology

IS - 4

ER -

Amelogenin as marker for bone marrow engraftment: A short-term study

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this